Sezgin Gunes
 Position
 Associate Professor
 Affiliation
 Department of Medical Biology , Ondokuz Mayis University, Samsun, Turkey
 Phone
 +90 543 640 01 18
 Email
 sgunes@omu.edu.tr
 Educations
 
1987-1992, B.Sc., Middle East Technical University, Turkey
 
1995-1999, M.Sc., Ondokuz Mayis University, Turkey
 
1999-2002, Ph.D., Ondokuz Mayis University, Turkey
 
 Experiences
 
2002-2011, Assistant Professor, Department of Medical Biology, Ondokuz Mayis University, Turkey
 
2011- , Associate Professor, Department of Medical Biology, Ondokuz Mayis University, Turkey
 
 Specialities
 
Association Studies
 
Gene Expression
 
Epigenetics
 
Cytogenetics
 
 Publication List
 
 Refereed Papers
 
[01]Gunes S, R. Asci, G. Okten, F. Atac, O. E. Onat, G. Ogur, O. Aydin, T. Ozcelik, H. Bagci. Three Males with SRY-Positive 46,XX Testicular Disorder of Sex Development, Syst Biol Reprod Med, 2012 Oct 30. [Epub ahead of print]
 
[02]Gunes S, Zeynep Yegin, Yurdanur Sullu, Recep Buyukalpelli, Hasan Bagci. SOX4 Expression Levels in Urothelial Bladder Carcinoma, Pathol Res Pract., 207(7), 423-7 (2011)
 
[03]Gunes S, Buyukalpelli R, Yegin Z. Genetic and Molecular Mechanisms in Bladder Cancer Development. Nova Publishers, New York, Chapter 5, 119-136.
 
[04]Altayli E, Gunes S. The Role of Molecular Mechanisms in the Development of Bladder Carcinoma. Turkiye Klinikleri J Med Sci., 31(1), 191-205 (2011).
 
[05]Pinarli FA, Okten G, Ozcelik T, Kara N, Gunes S, Kocak I. De Novo Balanced (X;14) Translocation In A Patient with Recurrent Miscarriages. Turkiye Klinikleri J Med Sci., 31(3), 712-5(2011).
 
[06]Okten G, Kara N,Gunes S, Tural S, Yigit S, Pinarli F. Retrospective Study Of Cases With Sex Chromosome Anomaly at Samsun and Around. Turkiye Klinikleri J Med Sci., 29(3), 643-7 (2009).
 
[07]Gunes S, Y. Acikgoz, N. Kara, G. Okten, O. Sezer Turkeli ve S. Yigit, Triploidy Syndrome With 69,XXX Karyotype, Turkiye Klinikleri J Med Sci, 27, 276-278 (2007).
 
[08]Gunes S, N. Kara, N. Gunal, S. Kucukoduk, G. Okten, S. Tural ve E. Taskin, A Case With Down Syndrome Presenting 21q22q Translocation,Turkiye Klinikleri J Med Sci., 27(6), 228-229 (2007).
 
[09]Gunes S, N. Kara, G. Okten, H.A. Tasdemir, O. Turkeli Sezer, S. Yigit ve G. Ogur, Familial T(1;17)(p34;q25) Balanced Translocation Carrier With Mental Retardation And Epilepsy Cases:Ħħ, Turkiye Klinikleri J Med Sci, 28(1), 83-86 (2008).
 
[10]Gunes S., N. Kara, B. Surucu, G. Okten, S. Yigit ve O. Sezer Turkeli, Two Turner Syndrome Patients With The Mosaic 45,X/46,X,i(Xq) Karyotype: Case Report, Turkiye Klinikleri J Med Sci, 28(2), 236-238 (2008).
 
[11]Gunes S., N. Kara ve H. Bagci, The Frequency of CCR5delta32 in Middle Black Sea Coastal Region Healthy Population, Turk. J. Med. Sci., 37 (1), 17-19 (2007).
 
[12]Okten G., Sezer O, Gunes S., Kucukoduk S, Ogur G. Two Cases of 9p Deletion Syndrome and A Case of 8q Trisomy with Partial 9p Monosomy. Genetic Counseling, 20(4), 341-347 (2009).
 
[13]Alayli G, Kara N, Tander B, Canturk F, Gunes S, Bagci H. Association of transforming growth factor beta1 gene polymorphism with rheumatoid arthritis in a Turkish population. Joint Bone Spine, 76(1), 20-3 (2009).
 
[14]Altayli E, Gunes S, Yilmaz AF, Goktas S, Bek Y. CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol., 41, 259-266 (2009).
 
[15]Kara N, Okten G, Gunes SO, Saglam Y, Tasdemir HA, Pinarli FA. An epileptic case with mosaic ring chromosome 6 and 6q terminal deletion. Epilepsy Res. 80(2-3), 219-23 (2008).
 
[16]Gunes S., Okten G., Kara N., Saglam Y., Tasdemir H.A., Kayacik E., Tural S. De Novo 18q Deletion with Mitral Valve Insufficiency. Genetic Counseling, 19(3), 261-265 (2008).
 
[17]Tander B., Gunes S., Boke O., Alayli G., Kara N., Bagci H., Canturk F. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int., 28(7), 685-91 (2008).
 
[18]Guven A., Kara N., Saglam Y., Gunes S., Okten G. CO-Occurrence The Mayer-Rokitansky-Kuster-Hauser and Gonadal Disgenesis Syndrome in a Girl with 45,X/46,X, del(X) (p11.21). Am. J. Med. Genet. A., 146(1), 128-131 (2008).
 
[19]Gunes S., Sumer A.P., Keles G.C., Kara N., Koprulu H., Bagci H., Bek Y. Analysis of Vitamin D Receptor Gene Polymorphism in Patients With Chronic Periodontitis. IJMR, 127(1), 58-64 (2008).
 
[20]Gunes S., Bagci H., Sarikaya S., Bilen C.Y., Kara N. Prostate-specific Antigen and 17 Hydroxylase Polymorphic Genotypes in Patients with Prostate Cancer and Benign Prostatic Hyperplasia. DNA and Cell Biol., 26(12), 873-8 (2007).
 
[21]Boke O., S. Gunes, Kara N., Aker S., Sahin A.R., Basar Y., Bagci H. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population. DNA Cell Biol., 26(8), 527-31 (2007).
 
[22]Kara N., Keles G.C., Sumer P, Gunes S., Bagci H., Koprulu H., Bek Y. Association of the polymorphisms in promoter and intron regions of the interleukin-4 gene with chronic periodontitis in a Turkish population. Acta. Odontol. Scand., 65(6), 292-297 (2007).
 
[23]Kara, N., N. Senturk, F. Aydin, Gunes S., H. Bagci, Y. Bek ve A.Y Turanli, Lack of Associat?on Between the G-2548A Polymorphism of the Leptin Gene with Psoriasis in a Turkish Population. Int. J. Derm., 46(12), 1271-1274 (2007).
 
[24]Sumer, P., N. Kara, G. Cayir Keles, Gunes S., H. Koprulu ve H. Bagci. Association of interleukin-10 gene polymorphisms with severe generalized chronic periodontitis. J. Periodontol., 78(3), 493-7 (2007).
 
[25]Aydin, F., N. Kara, N. Senturk, Gunes S., M. Canturk, H. Bagci, Y. Bek ve A. Turanli, Lack of association between leptin G2548A gene polymorphism and Behcet's disease. J. Eur. Acad. Dermatol. Venereol., 21(1), 68-71 (2007).
 
[26]Keles, G.C., Gunes S. , A.P. Sumer, M. Sumer, N. Kara, H. Bagci ve H. Koprulu, Association of Matrix Metalloproteinase-9 Promoter Gene Polymorphism With Chronic Periodontitis. J. Periodontol.,77(9), 1510-1514 (2006).
 
[27]Senturk, N., N. Kara, F. Aydin, Gunes S. , E.P. Yuksel, T. Canturk, H. Bagci ve A.Y. Turanli, Association of eNOS gene polymorphism (Glu298Asp) with psoriasis. J. Dermatol. Sci., 44, 52-55 (2006).
 
[28]Kara, N., N. Senturk, Gunes S.O. , H. Bagci, S. Yigit ve A.Y. Turanli, Lack of evidence for association between endothelial nitric oxide synthase gene polymorphism (glu298asp) with Behcet's disease in the Turkish population. Arch. Dermatol Res., 297(10), 468-71 (2006).
 
[29]Silig, Y., H. Pinarbasi, GunesS., S. Ayan, H. Bagci ve O. Cetinkaya, Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest., 24, 41-5 (2006).
 
[30]Gunes S., C.Y. Bilen, N. Kara, R. Asci, H. Bagci ve A.F. Yilmaz, Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol. Res., 34(1), 47-52 (2006).
 
Books
 
Gunes S, Buyukalpelli R, Yegin Z. Genetic and Molecular Mechanisms in Bladder Cancer Development. Nova Publishers, New York, Chapter 5, 119-136.
 
 Academic Activities
 
Paper Reviewer
 
Reviewer of JMCR
 
Reviewer of JCRCO
 
Reviewer of EJOGRB
 
Reviewer of Mutation Research
 
Reviewer of International Urology and Nephrology
 
Reviewer of DNA and Cell Biology
 
Reviewer of Urology Journal
 
 Courses
 
2005.09-2007.06, Medical Biology and Genetics
 
2002.09-2012.06, Research Principles
 
2002.09-2011.06, Cell Biology
 
2006.09-20012.06, Signal Transduction
 
2005.09-2006.06, Aging and Apoptosis
 
2005.06-2006.06, Cell and Tissue Culture Techniques
 
2007.09-2008.06, Molecular Pathologies and Gene Therapy
 
2008.09-2012.06, Molecular Biology of Cancer
 
2005.09-2011.06, Genetics Terminology
 
2005.09-2011.06, Special Subjects on Genetics
 
 Projects
 
2010-.03-2012.03, Modifying Genes and age at Onset in Huntington's Disease
 
2011-.03-2013.03, Vitamin D Receptor Gene Polymorphisms and Genetic Susceptibility Susceptibility in Multiple Sclerosis
 
2010.03-2012.06, Methylation Markers for Detection of Bladder Cancer
 
2004.03-2012.09, Y Chromosome Microdeletion in Oligospermic and Azoospermic Infertile Males
 
2009.09-2011.09, Erbb Receptor Tyrosine Kinases Family Expression Levels in Urothelial Bladder Carcinoma
 
2006.03-2008.03, The Effects of Metabolic Genes in Bladder Carcinoma
 
2008.09-2010.09, SOX4 Expression Levels in Urothelial Bladder Carcinoma